And today we are green with the rest of the market. There is some biotech news but at this point the sector is trading simply as a slightly higher beta.
China and trade seemed to be fading into the background potentially setting this week up for a decline of the highly correlated macro markets but Iran and the Middle East.
Well, yesterday ending up being a good day with the XBI eventually following the individual stocks but this continues to be a highly correlated macro market. The broader market seems.
Macro seems to once again dominate the trading with both Iran and China increasing the risk and both North Korea and Venezuela just below the surface. The odds remain that.
Not the best start to the week for the market with the surprise tariff news hitting the market. I would not be stunned for the effect to be muted given.
The sector continues to lag. What I see as a little odd is that pharma appears to be outperforming biotech. If Medicare for All was going to collapse the US.
Yesterday really ended up offering no real direction. We could not quite rally but we also did not quite collapse. Everything that I talked about yesterday about the trading of.
The sector has been struggling to say the least and when last I wrote, it was not clear to me the underlying cause, it is clear now (I will discuss.
It was not the ideal start to the week but also not the worst. The selling from the morning opening was bad but we may have bottomed in the afternoon.
The sector is certainly underperforming the broader markets and while that is frustrating, I do not see anything that is concerning. We did not get the breakout but if we.